A retrospective analysis of rosuvastatin verses other statins in patients with very high cardiovascular risk

Trial Profile

A retrospective analysis of rosuvastatin verses other statins in patients with very high cardiovascular risk

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Nov 2016

At a glance

  • Drugs Rosuvastatin (Primary) ; Atorvastatin; Ezetimibe/simvastatin; Fluvastatin; Lovastatin; Pravastatin; Simvastatin
  • Indications Cerebrovascular disorders; Coronary artery disease; Peripheral arterial disorders; Renal failure
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top